Fig. 1
From: Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease
Medicinal chemistry progression of the screening hit to VX-147.
Fig. 1 | Nature Communications
From: Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease
Medicinal chemistry progression of the screening hit to VX-147.
